Annual report pursuant to Section 13 and 15(d)

Asset Acquisitions - Divestiture of Emerald Health Therapeutics Canada, Inc. - Narrative (Details)

v3.24.1
Asset Acquisitions - Divestiture of Emerald Health Therapeutics Canada, Inc. - Narrative (Details)
Dec. 28, 2022
USD ($)
license
$ / shares
shares
Dec. 31, 2023
$ / shares
Dec. 31, 2022
$ / shares
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Common stock, par value (in dollars per share)   $ 0.001 $ 0.001
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Share Purchase Agreement      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Number of shares issued in transaction (in shares) | shares 11,776,338    
Common stock, par value (in dollars per share) $ 0    
Net proceeds from the transaction | $ $ 110,759    
Number of licenses transferred in divestiture | license 2